Wir sind mit live! Mehr erfahren

SS Innovations International

SSII

Börsenwert 507 Mio. $

2,53 USD

-0,05

1,94 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

1 Tag

-1,94 %

5 Tage

-3,07 %

1 Monat

-22,63 %

3 Monate

-29,92 %

6 Monate

-48,68 %

Seit Jahresbeginn

-55,22 %

1 Jahr

-70,85 %

5 Jahre

-77,71 %

10 Jahre

-77,71 %

Profil: SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Mitarbeiter: 483

Gesundheitswesen Medizintechnik

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 16,7 %

Neutral 83,3 %

Negativ 0 %

SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra

FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that, on October 5, 2026, the Company submitted its response to a request for additional information letter (the “AINN”) received from the United States Food and Drug Administration (the “FDA”) with regard to the Company's 510(k) submission for its SSi Mantra surgical robotic system (the “SSi Mantra”).

SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra

Zacks Investment Research

2 International Microcaps for Your Watchlist

SSII and IVDA have sales predominantly in India and Taiwan, respectively.

2 International Microcaps for Your Watchlist

Zacks Investment Research

Zacks Initiates Coverage of SSi With Neutral Recommendation

Discover why Zacks initiated coverage of SSII with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how expanding robotic surgery adoption, rising revenues and international growth are offset by persistent losses and regulatory hurdles.

Zacks Initiates Coverage of SSi With Neutral Recommendation

SS Innovations Provides Update on Continuing Progress and Milestones

-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company's continuing progress and milestones.

SS Innovations Provides Update on Continuing Progress and Milestones

SS Innovations Reports Second Quarter 2026 Financial Results

Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

IBN Initiates Coverage of SS Innovations International, Inc.

AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN , a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

IBN Initiates Coverage of SS Innovations International, Inc.

SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class

New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning

SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class

SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

Company celebrated for advancing global access to its innovative robotic surgery platform Company celebrated for advancing global access to its innovative robotic surgery platform

SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt